you'll have more options to help patients get a suitable atypical antipsychotic

February 2011

The approval of Latuda (lurasidone) means you'll have more options to help patients get a suitable atypical antipsychotic.

More money is spent on antipsychotics than any other class.

That's because these drugs are being used more for bipolar disorder, depression, autism, etc. Plus most cost $15 to $20 per day.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Psychiatry you'll have more options to help patients get a suitable atypical antipsychotic
Infectious Diseases New guidelines for treating methicillin-resistant S. aureus (MRSA) will change treatment of community-acquired skin infections
Neurology & Pain Prescription combo analgesics will be limited to only 325 mg of acetaminophen per tab or cap
Neurology & Pain Butrans (BYOO-trans), a new once-a-week C-III buprenorphine patch for chronic pain
Diabetes Cycloset, a new form of bromocriptine for type 2 diabetes
Cardiology questions about the safety of Multaq (dronedarone) for atrial fibrillation
Osteoporosis Atelvia (uh-TEL-vee-uh), a new delayed-release form of risedronate (Actonel), for postmenopausal osteoporosis
ADHD Kapvay (clonidine extended-release) for attention deficit hyperactivity disorder (ADHD) in children
Antidepressants confusion about generics for bupropion (Wellbutrin, Zyban, Budeprion, Buproban, etc)
Poison Prevention drugs that are toxic in young children
Vaccines CDC now recommends giving pertussis vaccine (Tdap) to SENIORS